WebFounded Date 2004. Founders Stephen Tullman. Operating Status Active. Last Funding Type Series C. Company Type For Profit. Contact Email [email protected]. Phone Number 610-640-2940. Ception Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need. WebPrincipal Rachel Lane, Ph.D. Background Rachel is a Principal based in Versant’s San Francisco office. She is a neurobiologist by training with more than 10 years of experience sourcing new opportunities and leading transactions in business development and portfolio strategy roles across the biotech industry. History
Inception Therapeutics - Products, Competitors, Financials, …
WebOct 2, 2013 · Principal, Versant Ventures and CBO, Inception Therapeutics San Francisco Bay Area 1K followers 500+ connections Join to view … WebInception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. Inception’s … chinapeer
Belharra Therapeutics LinkedIn
WebChinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases December 19, 2024 Pipeline Therapeutics Completes $30 Million Series B Financing August 22, 2024 Chinook therapeutics raises $65 million series a financing to advance precision medicines for kidney diseases May 16, 2024 WebOct 30, 2024 · INCEPTION THERAPEUTICS, INC. branch Company Number 4208719 Previous Company Numbers C4208719 Status Active Incorporation Date 30 October 2024 (over 4 years ago) Company Type Stock Corporation - Out of State - Stock Jurisdiction California (US) Branch Branch of INCEPTION THERAPEUTICS, INC. (Delaware (US)) … WebSince inception, Rakovina Therapeutics has also announced new patents and funding support from the National Research Council of Canada and the St. Baldricks Foundation. ... About Rakovina Therapeutics Inc. Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response … gramblingstate university online course